• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

赛乐西农可改善 DOCA-盐型高血压大鼠的心肾功能。

Serelaxin improves cardiac and renal function in DOCA-salt hypertensive rats.

机构信息

Renal Diseases and Hypertension, School of Medicine, University of Colorado ANSCHUTZ MEDICAL CAMPUS, Aurora, Colorado, 80045, USA.

Department of Pathology, School of Medicine, University of Colorado ANSCHUTZ MEDICAL CAMPUS, Aurora, Colorado, 80045, USA.

出版信息

Sci Rep. 2017 Aug 29;7(1):9793. doi: 10.1038/s41598-017-09470-0.

DOI:10.1038/s41598-017-09470-0
PMID:28851937
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5574886/
Abstract

Serelaxin, a recombinant form of the naturally occurring peptide hormone relaxin-2, is a pleiotropic vasodilating hormone that has been studied in patients with acute heart failure. In this study, the effects of serelaxin on cardiac and renal function, fibrosis, inflammation and lipid accumulation were studied in DOCA-salt treated rats. Uninephrectomized rats were assigned to two groups: controls provided with normal drinking water and DOCA provided with DOCA pellets and sodium chloride drinking water. After 4 weeks, the DOCA-salt rats were randomly selected and implanted with osmotic minipumps delivering vehicle or serelaxin for another 4 weeks. Treatment with serelaxin prevented cardiac and renal dysfunction in DOCA-salt rats. Serelaxin prevented cardiac and renal fibrosis, as determined by Picrosirius Red staining and Second Harmonic Generation (SHG) Microscopy. Treatment of DOCA-salt rats with serelaxin decreased renal inflammation, including the expression of TGF-β, NFκB, MCP-1, IL-1, IL-6, ICAM-1, VCAM-1 and CD68 macrophages. Serelaxin also decreased lipid accumulation in kidney in part by decreasing SREBP-1c, SREBP-2, ChREBP, FATP1, HMGCoAR, and LDL receptor, and increasing Acox1 and ABCA1. In summary, serelaxin reversed DOCA-salt induced cardiac and renal dysfunction.

摘要

Serelaxin,一种天然存在的激素松弛素-2 的重组形式,是一种多效性血管舒张激素,已在急性心力衰竭患者中进行了研究。在这项研究中,研究了 Serelaxin 对 DOCA-盐处理的大鼠心脏和肾功能、纤维化、炎症和脂质积累的影响。单侧肾切除大鼠分为两组:对照组提供正常饮用水,DOCA 组提供 DOCA 丸和氯化钠饮用水。4 周后,随机选择 DOCA-盐大鼠,并植入输送载体或 Serelaxin 的渗透微型泵再治疗 4 周。Serelaxin 可预防 DOCA-盐大鼠的心脏和肾功能障碍。Serelaxin 可预防心脏和肾脏纤维化,如通过苦味酸红染色和二次谐波产生(SHG)显微镜确定。Serelaxin 治疗 DOCA-盐大鼠可减少肾脏炎症,包括 TGF-β、NFκB、MCP-1、IL-1、IL-6、ICAM-1、VCAM-1 和 CD68 巨噬细胞的表达。Serelaxin 还通过减少 SREBP-1c、SREBP-2、ChREBP、FATP1、HMGCoAR 和 LDL 受体,增加 Acox1 和 ABCA1,部分减少了肾脏中的脂质积累。总之,Serelaxin 逆转了 DOCA-盐诱导的心脏和肾功能障碍。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3bd/5574886/d9f8337b2b83/41598_2017_9470_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3bd/5574886/2ed6ff1dd511/41598_2017_9470_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3bd/5574886/dd92b083dc90/41598_2017_9470_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3bd/5574886/7cf77146a8f1/41598_2017_9470_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3bd/5574886/ff6278b3588a/41598_2017_9470_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3bd/5574886/d9f8337b2b83/41598_2017_9470_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3bd/5574886/2ed6ff1dd511/41598_2017_9470_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3bd/5574886/dd92b083dc90/41598_2017_9470_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3bd/5574886/7cf77146a8f1/41598_2017_9470_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3bd/5574886/ff6278b3588a/41598_2017_9470_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3bd/5574886/d9f8337b2b83/41598_2017_9470_Fig5_HTML.jpg

相似文献

1
Serelaxin improves cardiac and renal function in DOCA-salt hypertensive rats.赛乐西农可改善 DOCA-盐型高血压大鼠的心肾功能。
Sci Rep. 2017 Aug 29;7(1):9793. doi: 10.1038/s41598-017-09470-0.
2
Combining mesenchymal stem cells with serelaxin provides enhanced renoprotection against 1K/DOCA/salt-induced hypertension.间质干细胞与 Serelaxin 联合应用可增强对 1K/DOCA/盐诱导的高血压的肾保护作用。
Br J Pharmacol. 2021 Mar;178(5):1164-1181. doi: 10.1111/bph.15361.
3
Comparing the renoprotective effects of BM-MSCs versus BM-MSC-exosomes, when combined with an anti-fibrotic drug, in hypertensive mice.比较骨髓间充质干细胞与骨髓间充质干细胞外泌体在与抗纤维化药物联合应用于高血压小鼠时的肾保护作用。
Biomed Pharmacother. 2021 Dec;144:112256. doi: 10.1016/j.biopha.2021.112256. Epub 2021 Oct 1.
4
CS-3150, a Novel Nonsteroidal Mineralocorticoid Receptor Antagonist, Shows Preventive and Therapeutic Effects On Renal Injury in Deoxycorticosterone Acetate/Salt-Induced Hypertensive Rats.新型非甾体类盐皮质激素受体拮抗剂CS-3150对醋酸脱氧皮质酮/盐诱导的高血压大鼠肾损伤具有预防和治疗作用。
J Pharmacol Exp Ther. 2016 Sep;358(3):548-57. doi: 10.1124/jpet.116.234765. Epub 2016 Jul 6.
5
Reversal of cardiac, vascular, and renal dysfunction by non-quinazoline α1-adrenolytics in DOCA-salt hypertensive rats: a comparison with prazosin, a quinazoline-based α1-adrenoceptor antagonist.非喹唑啉类 α1 肾上腺素能拮抗剂对 DOCA-盐高血压大鼠心、血管和肾功能的逆转作用:与基于喹唑啉的 α1 肾上腺素受体拮抗剂哌唑嗪的比较。
Hypertens Res. 2019 Aug;42(8):1125-1141. doi: 10.1038/s41440-019-0239-1. Epub 2019 Mar 12.
6
Anakinra reduces blood pressure and renal fibrosis in one kidney/DOCA/salt-induced hypertension.阿那白滞素可降低一侧肾脏/去氧皮质酮/盐诱导的高血压模型中的血压并减轻肾纤维化。
Pharmacol Res. 2017 Feb;116:77-86. doi: 10.1016/j.phrs.2016.12.015. Epub 2016 Dec 13.
7
Diosmin, a bioflavonoid reverses alterations in blood pressure, nitric oxide, lipid peroxides and antioxidant status in DOCA-salt induced hypertensive rats.地奥司明,一种生物类黄酮,可逆转 DOCA-盐诱导的高血压大鼠血压、一氧化氮、脂质过氧化物和抗氧化状态的改变。
Eur J Pharmacol. 2012 Mar 15;679(1-3):81-9. doi: 10.1016/j.ejphar.2011.12.040. Epub 2012 Jan 12.
8
ETA receptor blockade attenuates the hypertension but not renal dysfunction in DOCA-salt rats.内皮素A受体阻断可减轻DOCA-盐大鼠的高血压,但不能改善其肾功能障碍。
Am J Physiol. 1998 Jul;275(1):R245-52. doi: 10.1152/ajpregu.1998.275.1.R245.
9
Serelaxin attenuates renal inflammation and fibrosis in a mouse model of dilated cardiomyopathy.在扩张型心肌病小鼠模型中,松弛素可减轻肾脏炎症和纤维化。
Exp Physiol. 2018 Dec;103(12):1593-1602. doi: 10.1113/EP087189. Epub 2018 Nov 5.
10
Morin attenuates blood pressure and oxidative stress in deoxycorticosterone acetate-salt hypertensive rats: a biochemical and histopathological evaluation.Morin 可降低去氧皮质酮醋酸盐盐高血压大鼠的血压和氧化应激:生化和组织病理学评估。
Metabolism. 2012 Aug;61(8):1087-99. doi: 10.1016/j.metabol.2011.12.012. Epub 2012 Mar 3.

引用本文的文献

1
The renoprotective efficacy and safety of genetically-engineered human bone marrow-derived mesenchymal stromal cells expressing anti-fibrotic cargo.表达抗纤维化载物的基因工程人骨髓间充质基质细胞的肾保护疗效和安全性。
Stem Cell Res Ther. 2024 Oct 23;15(1):375. doi: 10.1186/s13287-024-03992-x.
2
Exploring the therapeutic effect of core components in Xuanshen Yishen mixture on hypertension through network pharmacology.基于网络药理学探讨玄参益肾合剂核心成分对高血压的治疗作用
Am J Transl Res. 2024 Jul 15;16(7):2877-2888. doi: 10.62347/MZGO7330. eCollection 2024.
3
Searching for Effective Treatments in HFpEF: Implications for Modeling the Disease in Rodents.

本文引用的文献

1
DOCA-Salt Hypertension: an Update.去氧皮质酮盐性高血压:最新进展
Curr Hypertens Rep. 2017 Apr;19(4):32. doi: 10.1007/s11906-017-0731-4.
2
Anti-Fibrosis Effect of Relaxin and Spironolactone Combined on Isoprenaline-Induced Myocardial Fibrosis in Rats via Inhibition of Endothelial-Mesenchymal Transition.松弛素与螺内酯联合应用通过抑制内皮-间充质转化对异丙肾上腺素诱导的大鼠心肌纤维化的抗纤维化作用
Cell Physiol Biochem. 2017;41(3):1167-1178. doi: 10.1159/000464125. Epub 2017 Mar 1.
3
Serelaxin as a potential treatment for renal dysfunction in cirrhosis: Preclinical evaluation and results of a randomized phase 2 trial.
寻找射血分数保留的心力衰竭的有效治疗方法:对啮齿动物疾病建模的启示
Pharmaceuticals (Basel). 2023 Oct 12;16(10):1449. doi: 10.3390/ph16101449.
4
Piezo1 channel activation facilitates baroreflex afferent neurotransmission with subsequent blood pressure reduction in control and hypertension rats.在正常和高血压大鼠中,Piezo1通道激活促进压力反射传入神经传递,随后降低血压。
Acta Pharmacol Sin. 2024 Jan;45(1):76-86. doi: 10.1038/s41401-023-01154-y. Epub 2023 Sep 5.
5
Relaxin-2 as a Potential Biomarker in Cardiovascular Diseases.松弛素-2作为心血管疾病的潜在生物标志物
J Pers Med. 2022 Jun 21;12(7):1021. doi: 10.3390/jpm12071021.
6
Enhancing the Therapeutic Potential of Mesenchymal Stromal Cell-Based Therapies with an Anti-Fibrotic Agent for the Treatment of Chronic Kidney Disease.用抗纤维化药物增强间充质基质细胞疗法的治疗潜力,用于治疗慢性肾脏病。
Int J Mol Sci. 2022 May 27;23(11):6035. doi: 10.3390/ijms23116035.
7
High-Fructose Diet Increases Renal β Expression, Leading to Intrarenal Fat Accumulation in a Rat Model with Metabolic Syndrome.高果糖饮食会增加大鼠代谢综合征模型肾脏中的β表达,导致肾内脂肪堆积。
Biology (Basel). 2022 Apr 18;11(4):618. doi: 10.3390/biology11040618.
8
Anti-apoptotic and Matrix Remodeling Actions of a Small Molecule Agonist of the Human Relaxin Receptor, ML290 in Mice With Unilateral Ureteral Obstruction.人松弛素受体小分子激动剂ML290在单侧输尿管梗阻小鼠中的抗凋亡和基质重塑作用
Front Physiol. 2021 Jul 7;12:650769. doi: 10.3389/fphys.2021.650769. eCollection 2021.
9
HDAC Inhibition Reverses Preexisting Diastolic Dysfunction and Blocks Covert Extracellular Matrix Remodeling.组蛋白去乙酰化酶抑制逆转预先存在的舒张功能障碍并阻止隐匿性细胞外基质重塑。
Circulation. 2021 May 11;143(19):1874-1890. doi: 10.1161/CIRCULATIONAHA.120.046462. Epub 2021 Mar 8.
10
ELABELA attenuates deoxycorticosterone acetate/salt-induced hypertension and renal injury by inhibition of NADPH oxidase/ROS/NLRP3 inflammasome pathway.埃贝拉通过抑制 NADPH 氧化酶/ROS/NLRP3 炎性小体通路来减轻脱氧皮质酮醋酸盐/盐诱导的高血压和肾脏损伤。
Cell Death Dis. 2020 Aug 22;11(8):698. doi: 10.1038/s41419-020-02912-0.
松弛素作为肝硬化肾功能不全的潜在治疗方法:临床前评估及随机2期试验结果
PLoS Med. 2017 Feb 28;14(2):e1002248. doi: 10.1371/journal.pmed.1002248. eCollection 2017 Feb.
4
Reperfusion therapy with recombinant human relaxin-2 (Serelaxin) attenuates myocardial infarct size and NLRP3 inflammasome following ischemia/reperfusion injury via eNOS-dependent mechanism.重组人松弛素-2(Serelaxin)再灌注治疗通过 eNOS 依赖机制减轻缺血/再灌注损伤后的心肌梗死面积和 NLRP3 炎性小体。
Cardiovasc Res. 2017 May 1;113(6):609-619. doi: 10.1093/cvr/cvw246.
5
Serelaxin treatment reverses vascular dysfunction and left ventricular hypertrophy in a mouse model of Type 1 diabetes.Serelaxin 治疗可逆转 1 型糖尿病小鼠模型的血管功能障碍和左心室肥厚。
Sci Rep. 2017 Jan 9;7:39604. doi: 10.1038/srep39604.
6
Exercise Training Attenuates Right Ventricular Remodeling in Rats with Pulmonary Arterial Stenosis.运动训练减轻肺动脉狭窄大鼠的右心室重塑
Front Physiol. 2016 Dec 5;7:541. doi: 10.3389/fphys.2016.00541. eCollection 2016.
7
Label-free fluorescence lifetime and second harmonic generation imaging microscopy improves quantification of experimental renal fibrosis.无标记荧光寿命和二次谐波产生成像显微镜改善了实验性肾纤维化的定量分析。
Kidney Int. 2016 Nov;90(5):1123-1128. doi: 10.1016/j.kint.2016.06.030. Epub 2016 Aug 21.
8
Serelaxin for the treatment of acute heart failure: a review with a focus on end-organ protection.Serelaxin 治疗急性心力衰竭:关注终末器官保护的综述。
Eur Heart J Cardiovasc Pharmacother. 2016 Apr;2(2):119-30. doi: 10.1093/ehjcvp/pvv046. Epub 2015 Nov 26.
9
Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis.肥胖相关性肾小球病:临床与病理特征及发病机制。
Nat Rev Nephrol. 2016 Aug;12(8):453-71. doi: 10.1038/nrneph.2016.75. Epub 2016 Jun 6.
10
Imaging Fibrosis and Separating Collagens using Second Harmonic Generation and Phasor Approach to Fluorescence Lifetime Imaging.利用二次谐波产生和荧光寿命成像的相量方法对纤维化进行成像并区分胶原蛋白。
Sci Rep. 2015 Aug 21;5:13378. doi: 10.1038/srep13378.